tiprankstipranks
Trending News
More News >
BioMarin Pharmaceutical (BMRN)
NASDAQ:BMRN
US Market

BioMarin Pharmaceutical (BMRN) Income Statement

Compare
2,362 Followers

BioMarin Pharmaceutical Income Statement

Last quarter (Q3 2025), BioMarin Pharmaceutical's total revenue was $776.13M, an increase of 4.08% from the same quarter last year. In Q3, BioMarin Pharmaceutical's net income was $-30.74M. See BioMarin Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.85B$ 2.42B$ 2.10B$ 1.85B$ 1.86B
Gross Profit
$ 2.27B$ 1.89B$ 1.59B$ 1.38B$ 1.34B
Operating Expenses
$ 1.79B$ 1.70B$ 1.43B$ 1.46B$ 1.38B
Depreciation and Amortization
$ 96.43M$ 104.39M$ 101.97M$ 108.04M$ 105.17M
EBITDA
$ 650.53M$ 306.77M$ 265.36M$ 47.43M$ 83.66M
Operating Income
$ 484.21M$ 185.77M$ 160.97M$ -82.34M$ -43.44M
Other Income/Expenses
$ 57.55M$ 2.79M$ -11.40M$ 6.99M$ -5.56M
Pretax Income
$ 541.76M$ 188.56M$ 149.58M$ -75.35M$ -49.00M
Net Income
$ 426.86M$ 167.65M$ 141.56M$ -64.08M$ 854.03M
Per Share Metrics
Basic EPS
$ 2.25$ 0.89$ 0.76$ -0.35$ 4.75
Diluted EPS
$ 2.21$ 0.88$ 0.75$ -0.35$ 4.53
Weighted Average Shares Outstanding
190.03M 187.83M 185.27M 182.85M 180.80M
Weighted Average Shares Outstanding (Diluted)
196.71M 191.59M 188.96M 182.85M 191.68M
Currency in USD

BioMarin Pharmaceutical Earnings and Revenue History